510(k) Report

510(k) · Cleared

Cleared

All Slicone Drainage, Penrose Drain, CWV Drain, Thoracic Drain Tubes and CWV Reservoir

K980917510(k) TraditionalCleared May 27, 199877-day reviewClass II21 CFR 876.5010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fortune Medical Instrument Corp. · GCA Biliary Catheter For Stone Removal That May Also Allow For Irrigation And Contrast Injection

Cleared on May 27, 1998 after a 77-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
May 27, 1998
Review
77 days
Class
Class II
Product code
GCA
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K980917Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GCA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GCA device

  1. #1 K253013 Disposable Stone Retrieval Balloon Catheterscore 12.2 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All GCA devices

GCA Biliary Catheter For Stone Removal That May Also Allow For Irrigation And Contrast Injection: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GCA

1in 2024

2007: 12017: 12018: 22019: 12020: 22021: 12022: 12024: 12026 (partial year): 1
2007high 2 (2018) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GCA

Too few GCA 510(k)s in any year since 2007 to give a median.

Recalls per year · GCA

No recall names GCA since 2007.

Adverse event reports per year · GCA

24in 2025

2007: 62008: 362009: 342010: 122011: 102012: 92013: 102014: 112015: 202016: 142017: 852018: 382019: 382020: 202021: 82022: 182023: 112024: 142025: 24
2007high 85 (2017) · low 6 (2007)2025

MAUDE reports naming product code GCA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—06
20080—036
20090—034
20100—012
20110—010
20120—09
20130—010
20140—011
20150—020
20160—014
20171—085
20182—038
20191—038
20202—020
20211—08
20221—018
20230—011
20241—014
20250—024
20261—0—

What is it indicated for?

To preserve patency of the common duct and to ensure drainage of bile out of the body until edema in the common duct has subsided enough for bile to drain into the duodenum normally. The T-Y Drainage Tube is also allowed for flush in the common duct.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K980917: All Slicone Drainage, Penrose Drain, CWV Drain, Thoracic Drain Tubes and CWV Reservoir.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K980917

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026